Staying ahead of the technology curve means strengthening your competitive advantage. That is why we give you data-driven innovation insights into the healthcare industry. This time, you get to discover 5 hand-picked precision medicine startups.
Global Startup Heat Map: 5 Top Precision Medicine Startups
The 5 precision medicine startups you will explore below are chosen based on our data-driven startup scouting approach, taking into account factors such as location, founding year, and relevance of technology, among others. This analysis is based on the Big Data & Artificial Intelligence (AI)-powered StartUs Insights Discovery Platform, covering over 1.3 million startups & scaleups globally.
The Global Startup Heat Map below highlights the 5 precision medicine startups & scaleups our Innovation Researchers curated for this report. Moreover, you get insights into regions that observe a high startup activity and the global geographic distribution of the 479 companies we analyzed for this specific topic.
Click to download
Oncxerna develops an AI-based Ribonucleic Acid (RNA) Platform
The research and development to find a cure for cancer has been an ongoing challenge for the medical field resulting in continuous improvements in cancer treatments. One of the directions in cancer treatment research is to analyze cancer-causing mutations in the genome. Startups and scaleups are developing research platforms and techniques to better understand the underlying causes of cancer.
US-America startup OncXerna develops an RNA expression biomarker panel (TME Panel-1) that is specific to the tumor microenvironment (TME). The solution allows clinical researchers to develop algorithms for effective treatment using RNA signature derived from biomarker panels. The solution aims to match the patient to the treatment rather than generalizing treatments for the whole population.
Perceiv AI enables Intelligent Patient Selection
In the field of medical research, it is desirable to involve a higher number of diverse patients or volunteers. This allows researchers to account for all the diversity of biological factors within individuals which may affect research results. Startups and scaleups are developing platforms to analyze multiple biometric parameters to find highly eligible candidates to suit each medical trial.
Canadian startup Perceiv AI provides an AI-driven system for intelligent patient selection. The startup’s proprietary platform uses different data types including imaging, genetic, phenotypic, and clinical variables to identify patients for clinical trials. The data is then analyzed using machine learning to find patients whose biomarkers are most suitable for the specified clinical trial. Some areas of precision medicine that benefit from the platform are in the treatment of Alzheimer’s disease and acute coronary syndrome.
Precomb Therapeutics creates Drug Profiling solutions
Cancer treatment has been the focus of many medical researchers for many years. Developing cancer treatments is difficult due to variations between types of cancer, each with its own treatment process. Additionally, factors such as the biology of the patient affect the required cure for cancer. Startups are shifting focus in cancer treatment development from generalized treatment protocols to personalized medicine.
Swiss biotech startup PreComb Therapeutics specializes in in-vitro cancer drug testing to improve cancer cure management. Their technology uses automated microtumor-based profiling and easily integrates with existing on-site equipment in the hospital. The microtumor test technology is fully automated and works as a standalone solution.
AUM Biosciences specializes in Biomarker Detection
Among major types of cancer, surgically incurable cancers are especially difficult to treat. Treatments such as chemotherapy and radiation therapy place a tremendous physical, mental and financial strain on the patient. Cancer treatment researchers and startups are using advancements in microbiology to identify the basic biomarkers that cause cancer and create more effective therapeutics.
Singaporean startup AUM Biosciences develops a biomarker-based drug discovery process to create cancer therapeutics. Their platform focuses on small molecule inhibitors that target critical genomic drivers of cancer. The small molecule inhibitors are selected to target choke points in cell signaling and survival pathways. The startup’s solution simultaneously screens for multiple targets critical for cancer cell growth, survival, and metastases, enabling rapid and cost-efficient drug discovery.
AceTech provides Supportive Care Solutions
Modern medical treatment providers intend to make cures as effective as possible while minimizing negative side effects. However, this is not always possible especially in the case of treatment of diseases such as cancers. Moreover, precision medicine solutions in oncology are often more focused on the cancer cells themselves rather than the overall patient’s condition as a result. Startups are working on proactive solutions that treat cancers before symptoms occur.
Israeli startup AceTech provides healthcare professionals with precision medicine software tools for supportive care. RadiaApp provides a customized treatment plan for the management and prevention of radiation dermatitis throughout radiotherapy treatments. OralApp focuses on oral mucositis throughout radiotherapy and chemotherapy treatments. The startup’s solutions allow physicians to provide tailor-made treatments to prevent side effects of common medical treatments.
Discover more Healthcare startups
To keep you up-to-date on the latest technology and emerging solutions, we provide you with actionable innovation intelligence – quickly and exhaustively. You can download one of our free Healthcare Innovation Report and discover new business opportunities or save your time & let us look into your areas of interest. We provide you with an exhaustive overview of new startups, scaleups & emerging technologies that matter to you.
